期刊文献+

调节性T细胞在再生障碍性贫血发病机制中的作用 被引量:2

下载PDF
导出
摘要 再生障碍性贫血(以下简称再障)是以骨髓造血衰竭和全血细胞减少为主要特征的血液系统疾病。再障发病的主要机制:(1)造血干细胞缺陷,即“种子”学说;(2)机体的免疫异常,即“虫子”学说;造血微环境异常,即“土壤学说”。大约70%的再障与免疫紊乱有关。1995年Sakaguchi等首次报道CD4+CD25+调节性T细胞(regulatory Tcells,Tregs)。随着对Tregs生物学特性、功能特点等的深入研究,发现,Tregs是具有免疫抑制功能的细胞群,其独特的免疫调节作用,能对潜在的、具有伤害性的自身反应性细胞进行调控,诱导和维持自身免疫耐受,其数量缺乏和功能紊乱会导致严重或致命的自身免疫性疾病。
出处 《浙江临床医学》 2010年第4期421-423,共3页 Zhejiang Clinical Medical Journal
  • 相关文献

参考文献21

  • 1Elena E,Solomou,Katayoun Rezvani,et al.Deficient CD4^+ CD25^+ FOXP+3T regulatory cells in acquired aplastic anemia.Blood,2007,110:1603-1606. 被引量:1
  • 2Shevach EM,Dipaolo RA,Andersson J,et al.The lifestyle of naturally occurring CD4^+ CD25^+ Foxp+3 regulatory T cells.Immunol Rev,2006,212:60-73. 被引量:1
  • 3Sakaguchi S,Ono M,Setoguchi R,et al.CD4^+ CD25^+ Foxp3^+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.Immunol Rev,2006,212:8-27. 被引量:1
  • 4Chatila TA.Role of regulatory T cells in human diseases.Allergy Clin Immunol,2005,116(5):949-959. 被引量:1
  • 5Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3.Science,2003,299:1057-1061. 被引量:1
  • 6Shevach EM.CD4^+ CD25^+ suppressor T cells:more questions than answers.Nat Rev Immunol,2002,2:389-400. 被引量:1
  • 7Marc Beyer,Joachim L,Schultze.Regulatory T cells in cancer.Blood,2006,108:804-811. 被引量:1
  • 8Olaf Rtzschke,Giovanna Borsellino,Luca Battistini,et al.In vivo-activated CD+103 Foxp+3 Tregs:of men and mice.Blood,2009,113:2119-2120. 被引量:1
  • 9Shimizu J,Yamazaki S,Takahashi T,et al.Stimulation of CD25^+ CD4^+ regulatory T cells through GITR breaks immunological self-tolerance.Nat Immunol,2002,3:135-142. 被引量:1
  • 10Isme'de Kleer,Bas Vastert.Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4^+ CD25^+ immune regulatory network.Blood,2006,107:1696-1702. 被引量:1

二级参考文献10

  • 1Young N S. Hematopoietic cell destruction by immune mechanism in acquired aplastic anemia [ J ]. Semin Hematol, 2000; 37 ( 1 ) : 3-14. 被引量:1
  • 2Young N S. Acquired alplastic anemia [J]. JAMA, 1999;282 (3) :271- 278. 被引量:1
  • 3Sakaguchi S, Sakaguchi N, Asano M et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerancecauses various autoimmune diseases [J] .J Immunol, 1995;155(3) : 1151-1164. 被引量:1
  • 4Pieca C C, Caton A J. The role of self-peptides in the development of CD4 ^+ CD25 ^+ regulatory T cells [ J ]. Curt Opin hmmmol, 2005 ; 17 ( 4 ) : 131-136. 被引量:1
  • 5Shevach E M. CD4^+ CD25 ^+ suppressor T cells : More questions than answers [J]. Nat Rev hnmunol,20(/2;2(6):389-400. 被引量:1
  • 6Sakaguchi S. The origin of FOXP3-expressing CD4^+ regulatory T cells: Thymus or periphery [ J]. J Clin Invest, 2003; 112(9) : 1310-1322. 被引量:1
  • 7Young N S, Calado R T, Scheinberg Pet al. Current concepts in the pathophysiology and treatment of aplastic anemia [ J]. Blood, 2006; 108 (8) :2509-2519. 被引量:1
  • 8Young N S. Autoimmunity and its treatment in aplastic anemia [J]. Ann Intern Med, 1997; 126(2) : 166-168. 被引量:1
  • 9Solomou E E, Rezvani K, Mielke S et al. Deficient CD4^+ CD25^+ FOXP3^+ T regulatory ceils in acquired aplastic anemia [ J ]. Blood, 2007; 110(5) : 1603-1606. 被引量:1
  • 10Annacker O, Pimenta Araujo R, Bunrien Defranouxo et al. On the ontogeny and physiology of regulatory T cells [J]. Immunol Rev,2001 ; 182 (8):5-17. 被引量:1

共引文献13

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部